Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound design.
Richters A, Ketzer J, Getlik M, Grütter C, Schneider R, Heuckmann JM, Heynck S, Sos ML, Gupta A, Unger A, Schultz-Fademrecht C, Thomas RK, Bauer S, Rauh D.
Richters A, et al. Among authors: rauh d.
J Med Chem. 2013 Jul 25;56(14):5757-72. doi: 10.1021/jm4004076. Epub 2013 Jul 10.
J Med Chem. 2013.
PMID: 23773153